Log in
Forgot password ?
Become a member for free
Sign up
Sign up
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Swiss Exchange  >  Roche Holding Ltd.    ROG   CH0012032048

My previous session
Most popular
Analysis summaryMarketScreener Strategies

Ulrich Ebensperger

Financial Analyst
share with twitter share with LinkedIn share with facebook
share via e-mail

A medium term support level to take advantage of

Strategy published on 10/19/2016 | 09:09
long trade
Stop-loss triggered
Entry price : 234.8CHF | Target : 243CHF | Stop-loss : 232CHF | Potential : 3.49%
The selling pressure regarding Roche Holding Ltd. shares could subside shortly. In fact, the support area that is currently being tested around 232.7 CHF has come into play and could, at least in the short term, keep the downside pressure at bay.
Investors have an opportunity to buy the stock and target the CHF 243.
  • The current area is a good opportunity for investors interested in buying the stock in a mid or long-term perspective. Indeed, the share is moving closer to its lower bound at CHF 233.2 CHF in weekly data.
  • The close medium term support offers good timing for purchasing the stock.
  • Margins returned by the company are among the highest on the stock exchange list. Its core activity clears big profits.
  • The company is in a robust financial situation considering its net cash and margin position.
  • This company will be of major interest to investors in search of a high dividend stock.
  • Analysts covering this company mostly recommend stock overweighting or purchase.
  • The average target price set by analysts covering the stock is above current prices and offers a tremendous appreciation potential.

  • Financial statements have repeatedly disappointed market stakeholders. Most often, they were below expectations.
  • The company's enterprise value to sales, at 4.1 times its current sales, is high.
  • For the past seven days, analysts have been lowering their EPS expectations for the company.
share with twitter share with LinkedIn share with facebook
share via e-mail

Disclaimer: The information, charts, data, views, or comments provided by SURPERFORMANCE SAS are intended for investors who have the necessary knowledge and experience to understand and appreciate the information contained within. These items are disseminated for personal reference only. They do not constitute an offer or solicitation to buy or sell financial products or services, nor an investment advice.
The use of the information disseminated takes place under the investor's sole responsibility, without recourse against SURPERFORMANCE SAS. SURPERFORMANCE SAS will not be liable, whether in contract, in tort, under any warranty, for errors, omissions, improper investments, or adverse evolution of markets.

Financials (CHF)
Sales 2018 56 475 M
EBIT 2018 19 233 M
Net income 2018 12 946 M
Debt 2018 4 708 M
Yield 2018 3,74%
P/E ratio 2018 15,54
P/E ratio 2019 15,24
EV / Sales 2018 3,67x
EV / Sales 2019 3,52x
Capitalization 203 B
Surperformance© ratings
Fundamental ratings
Overall rating
Trading Rating
Investor Rating
Growth (Revenue)
Earnings quality
Business Predictability
P/E ratio
7 days EPS revision
4 months EPS revision
1 year EPS revision
4 months Revenue revision
1 year Revenue revision
Technical ratings
Short Term Timing
Middle Term Timing
Long Term Timing
Bollinger Spread
Unusual Volumes
Duration : Period : Day
Roche Holding Ltd. Technical Analysis Chart | MarketScreener
Duration : Period : Week
Roche Holding Ltd. Technical Analysis Chart | MarketScreener